Ranitidine and Cosopt drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ranitidine (ranitidine) and Cosopt (dorzolamide hydrochloride; timolol maleate). Common drug interactions include disease progression among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Ranitidine and Cosopt. It is created by eHealthMe based on reports of 49 people who take the same drugs from the FDA, and is updated regularly.

What is Ranitidine?

Ranitidine has active ingredients of ranitidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 234,475 Ranitidine users. Check the latest studies of Ranitidine.

What is Cosopt?

Cosopt has active ingredients of dorzolamide hydrochloride; timolol maleate. It is often used in glaucoma. eHealthMe is studying from 9,029 Cosopt users. Check the latest studies of Cosopt.



On Jul, 06, 2026

49 people who take Ranitidine and Cosopt together, and have interactions are studied.

Ranitidine and Cosopt drug interactions.

What are the common drug interactions of Ranitidine and Cosopt, by gender? *:

female:

  1. Disease progression
  2. Drug ineffective
  3. Eye irritation
  4. Eyelid pain
  5. Faecal incontinence (a lack of control over passing stool)
  6. Fall
  7. Hallucination, visual (seeing things that aren't there)
  8. Hip fracture
  9. Hyperhidrosis (abnormally increased sweating)
  10. Hypersensitivity

male:

  1. Renal failure (kidney dysfunction)
  2. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  3. General physical health deterioration (weak health status)
  4. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  5. Retching (strong involuntary effort to vomit)
  6. Angioplasty
  7. Blindness unilateral
  8. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  9. Blood pressure increased
  10. Corneal scar (nullah)

What are the common drug interactions of Ranitidine and Cosopt, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Renal tubular necrosis (death of kidney tubules)
  2. Transaminases increased
  3. Wheezing (a high-pitched whistling sound made while you breath)
  4. Abdominal distension
  5. Acute respiratory failure
  6. Anxiety
  7. Bacterial infection
  8. Blood creatinine increased
  9. Cardiac arrest
  10. Hyperchloraemia (an excess of chlorides in the blood)

30-39:

n/a

40-49:

  1. Bursitis infective (the bursa can become infected, this is called infected bursitis)

50-59:

  1. Conjunctivitis (pink eye)
  2. Ear congestion
  3. Eye discharge
  4. Eye haemorrhage (bleeding in the eye)
  5. Eye infection viral
  6. Eye pain
  7. Growth of eyelashes
  8. Lacrimation increased
  9. Pain
  10. Pyrexia (fever)

60+:

  1. Nausea (feeling of having an urge to vomit)
  2. Pain
  3. Chronic kidney disease
  4. General physical health deterioration (weak health status)
  5. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  6. Retching (strong involuntary effort to vomit)
  7. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  8. Anaphylactic reaction (serious allergic reaction)
  9. Anxiety
  10. Aortic arteriosclerosis (hardening of the aortic arteries)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 6 people, 12.24%
  2. Stable Angina (a constant chest pain): 4 people, 8.16%
  3. Osteoporosis (bones weak and more likely to break): 4 people, 8.16%
  4. High Blood Pressure: 3 people, 6.12%

* Approximation only. Some reports may have incomplete information.

Do you take Ranitidine and Cosopt?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ranitidine and Cosopt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ranitidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cosopt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ranitidine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cosopt and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ranitidine and dorzolamide hydrochloride; timolol maleate (the active ingredients of Ranitidine and Cosopt, respectively), and Ranitidine and Cosopt (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: